473 related articles for article (PubMed ID: 1329560)
1. Ouabainlike factor in Milan hypertensive rats.
Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of a ouabain-like factor from Milan hypertensive rats.
Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S75-8. PubMed ID: 7508036
[TBL] [Abstract][Full Text] [Related]
3. Role of the ouabain-like factor and Na-K pump in rat and human genetic hypertension.
Ferrandi M; Manunta P; Rivera R; Bianchi G; Ferrari P
Clin Exp Hypertens; 1998; 20(5-6):629-39. PubMed ID: 9682919
[TBL] [Abstract][Full Text] [Related]
4. Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays.
Ferrandi M; Manunta P; Balzan S; Hamlyn JM; Bianchi G; Ferrari P
Hypertension; 1997 Oct; 30(4):886-96. PubMed ID: 9336389
[TBL] [Abstract][Full Text] [Related]
5. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of Na-K-ATPase in human urine: effects of ouabain-like factors and of vanadium-diascorbate on calcium mobilization in rat vascular smooth muscle cells: comparison with the effects of ouabain, angiotensin II, and arginine-vasopressin.
Meyer-Lehnert H; Bäcker A; Kramer HJ
Am J Hypertens; 2000 Apr; 13(4 Pt 1):364-9. PubMed ID: 10821337
[TBL] [Abstract][Full Text] [Related]
7. PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension.
Ferrari P; Ferrandi M; Tripodi G; Torielli L; Padoani G; Minotti E; Melloni P; Bianchi G
J Pharmacol Exp Ther; 1999 Mar; 288(3):1074-83. PubMed ID: 10027844
[TBL] [Abstract][Full Text] [Related]
8. Human adrenal cells in culture produce both ouabain-like and dihydroouabain-like factors.
el-Masri MA; Clark BJ; Qazzaz HM; Valdes R
Clin Chem; 2002 Oct; 48(10):1720-30. PubMed ID: 12324489
[TBL] [Abstract][Full Text] [Related]
9. Secretion of a lactone-hydrogenated ouabain-like effector of sodium, potassium-adenosine triphosphatase activity by adrenal cells.
Qazzaz HM; El-Masri MA; Valdes R
Endocrinology; 2000 Sep; 141(9):3200-9. PubMed ID: 10965891
[TBL] [Abstract][Full Text] [Related]
10. Erythrocyte sodium pump stimulation by ouabain and an endogenous ouabain-like factor.
Balzan S; D'Urso G; Nicolini G; Forini F; Pellegrino M; Montali U
Cell Biochem Funct; 2007; 25(3):297-303. PubMed ID: 17191274
[TBL] [Abstract][Full Text] [Related]
11. Ouabain-like factors in human urine: identification of a Na-K-ATPase inhibitor as vanadium-diascorbate adduct.
Kramer HJ; Krampitz G; Bäcker A; Meyer-Lehnert H
Clin Exp Hypertens; 1998; 20(5-6):557-71. PubMed ID: 9682912
[TBL] [Abstract][Full Text] [Related]
12. Binding of ouabain and human ouabainlike substance to different Na+, K+-ATPase isoforms.
Butt AN; Tennant BP; Gillingwater SD; Shepherd PS; Swaminathan R
Hypertens Res; 2000 Sep; 23 Suppl():S45-50. PubMed ID: 11016819
[TBL] [Abstract][Full Text] [Related]
13. Further biochemical characterization of an Na+ pump inhibitor purified from human urine.
Crabos M; Grichois ML; Guicheney P; Wainer IW; Cloix JF
Eur J Biochem; 1987 Jan; 162(1):129-35. PubMed ID: 3028785
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of human urine-derived digitalis-like factor.
Goto A; Yamada K; Ishii M; Yoshioka M; Ishiguro T; Eguchi C; Sugimoto T
Biochem Biophys Res Commun; 1988 Aug; 154(3):847-53. PubMed ID: 2841934
[TBL] [Abstract][Full Text] [Related]
15. Age-dependency and dietary influence on the hypothalamic ouabain-like factor in Milan hypertensive rats.
Ferrandi M; Minotti E; Florio M; Bianchi G; Ferrari P
J Hypertens; 1995 Dec; 13(12 Pt 2):1571-4. PubMed ID: 8903611
[TBL] [Abstract][Full Text] [Related]
16. The change and significance of the Na+-K+-ATPase alpha-subunit in ouabain-hypertensive rats.
Tian G; Dang C; Lu Z
Hypertens Res; 2001 Nov; 24(6):729-34. PubMed ID: 11768735
[TBL] [Abstract][Full Text] [Related]
17. Positive inotropic effects of the endogenous Na+/K(+)-transporting ATPase inhibitor from the hypothalamus.
Hallaq HA; Haupert GT
Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10080-4. PubMed ID: 2557617
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of a digoxin-like immunoreactive substance from human urine by affinity chromatography.
De Angelis C; Riscazzi M; Salvini R; Piccoli A; Ferri C; Santucci A
Clin Chem; 1997 Aug; 43(8 Pt 1):1416-20. PubMed ID: 9267322
[TBL] [Abstract][Full Text] [Related]
19. Sodium pump inhibition and regional expression of sodium pump alpha-isoforms in lens.
Tao QF; Hollenberg NK; Graves SW
Hypertension; 1999 Nov; 34(5):1168-74. PubMed ID: 10567200
[TBL] [Abstract][Full Text] [Related]
20. Production of ouabain-like factor in normal and ischemic rat heart.
D'Urso G; Frascarelli S; Balzan S; Zucchi R; Montali U
J Cardiovasc Pharmacol; 2004 May; 43(5):657-62. PubMed ID: 15071352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
